Endo and Terada indicated that aberrant expression of CD44s and CD44v (CD44v5, CD44v6, CD44v7-8, and CD44v10) was correlated with poor prognosis in HCC, and a link between CD44v6 and high p53 expression in HCC was also suggested in the study, as determined using immunohistochemical analysis [44]. Here, TP53 is linked to hepatocellular carcinoma.